Are Newer Drugs Better? An Analysis of Neonatal Pharmacological Treatments across Generations

10 June

Written By Krista Verlis

Nai Ming Lai, Sajesh Kalkandi Veettil, Nathorn Chaiyakunapruk, Paul Glasziou

Med Princ Pract (2024) 33 (5): 471–477.

Big pharmaPrescribingRandomised control trial (RCT)

Krista Verlis

How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry

Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review